Patent details

Basic Information

Publication number:

EP2651391

PCT Application Number:

EP2011072933

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP117994202

PCT Publication Number:

WO2012080408

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION INTENDED TO PREVENT MISUSE

French Title of Invention:

COMPOSITION PHARMACEUTIQUE DESTINEE A EVITER L'ABUS PAR DES TIERS

German Title of Invention:

PHARMAZEUTISCHE ZUSAMMENSETZUNG ZUR ORALEN VERABREICHUNG BESTIMMT UM MISSBRAUCH ZU VERHINDERN

SPC Number:

Dates

Filing date:

15/12/2011

Grant date:

23/01/2019

EP Publication Date:

23/10/2013

PCT Publication Date:

21/06/2012

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

23/01/2019

EP B1 Publication Date:

23/01/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

15/12/2019

Expiration date:

15/12/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

16/01/2019

 

 

Name:

SANOFI

Address:

54, rue La Boétie, 75008 Paris, France (FR)

Inventor

1

Name:

ROUGEOT, Olivier

Address:

France (FR)

2

Name:

YAGUCHI, Yoshikatsu

Address:

France (FR)

3

Name:

MARTINEZ, Annick

Address:

France (FR)

Priority

Priority Number:

1060655

Priority Date:

16/12/2010

Priority Country:

France (FR)

Classification

IPC classification:

A61K 9/00; A61K 9/20; A61K 9/46; A61K 9/50; A61K 31/437; A61K 31/4985; A61K 33/10; A61K 47/02; A61P 25/20;

Publication

European Patent Bulletin

Issue number:

201904

Publication date:

23/01/2019

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages